A Study Comparing Siplizumab With Rabbit Anti-Thymocyte Globulin to Help the Body Accept a Kidney Transplant
Clinical trial NCT07508787 · RECRUITING
Trial details
- NCT number
- NCT07508787
- Sponsor
- Nefro Avillion Clinical Development, LLC
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-29
- Primary completion
- 2028-03-28
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.